IN8bio, Inc. (INAB)
USD 0.27
(-6.77%)
USD 0.27
(-6.77%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 2.5 Million | 1.1 Million | 251 Thousand | 96 Thousand | 96 Thousand | 96 Thousand |
| Gross Profit | -2.5 Million | -1.1 Million | -251 Thousand | -96 Thousand | -96 Thousand | -96 Thousand |
| Operating Expenses | 30.33 Million | 28.52 Million | 14.65 Million | 8.55 Million | 5.06 Million | 2 Million |
| Selling, General and Administrative Expenses | 13.51 Million | 14.45 Million | 7.3 Million | 3.17 Million | 2.7 Million | 1.42 Million |
| Research and Development Expenses | 16.82 Million | 14.06 Million | 7.34 Million | 5.37 Million | 2.35 Million | 581 Thousand |
| Other Expenses | - | - | - | - | - | -63 Thousand |
| Cost and Expenses | 30.33 Million | 28.52 Million | 14.65 Million | 8.55 Million | 5.06 Million | 2 Million |
| Operating Income | -30.33 Million | -28.52 Million | -14.65 Million | -8.55 Million | -5.13 Million | -2 Million |
| Interest Expense | - | - | - | - | - | 14 Thousand |
| Income Tax Expense | - | -1.1 Million | 551.44 Thousand | -118.29 Thousand | -68 Thousand | -63 Thousand |
| Earnings before Tax | -30 Million | -28.52 Million | -14.65 Million | -8.55 Million | -5.13 Million | -2.08 Million |
| Net Income | -30 Million | -27.41 Million | -14.65 Million | -8.55 Million | -5.13 Million | -2.08 Million |
| Earnings Per Share Basic | -1.00 | -1.31 | -0.78 | -0.44 | -0.27 | -0.34 |
| Earnings Per Share Diluted | -1.00 | -1.31 | -0.78 | -0.44 | -0.27 | -0.34 |
| Weighted Average Shares Outstanding | 29.86 Million | 20.96 Million | 18.78 Million | 19.35 Million | 19.35 Million | 6.17 Million |
| Weighted Average Shares Outstanding (Diluted) | 29.86 Million | 20.96 Million | 18.78 Million | 19.35 Million | 19.35 Million | 6.17 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -28.5 Million | -27.41 Million | -14.4 Million | -8.46 Million | -5.03 Million | -1.97 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 3.74 Million | - | - | - |
| Cost of Revenue | 631 Thousand | 632 Thousand | 627 Thousand | 2.5 Million | 647 Thousand | 637 Thousand |
| Gross Profit | -631 Thousand | -632 Thousand | 3.12 Million | -2.5 Million | -647 Thousand | -637 Thousand |
| Operating Expenses | 8.05 Million | 8.64 Million | 6.97 Million | 27.83 Million | 7.16 Million | 7.71 Million |
| Selling, General and Administrative Expenses | 2.9 Million | 3.74 Million | 2.44 Million | - | 3.38 Million | 3.58 Million |
| Research and Development Expenses | 5.15 Million | 4.9 Million | 4.52 Million | - | 3.78 Million | 4.13 Million |
| Other Expenses | -60 Thousand | - | 330 Thousand | 16.82 Million | - | - |
| Cost and Expenses | 8.68 Million | 8.64 Million | 7.59 Million | 30.33 Million | 7.16 Million | 7.71 Million |
| Operating Income | -8.68 Million | -8.56 Million | -7.59 Million | -30.33 Million | -7.16 Million | -7.71 Million |
| Interest Expense | - | - | 590 Thousand | - | - | - |
| Income Tax Expense | - | -632 Thousand | -7.59 Million | -32.83 Million | -647 Thousand | 514.91 Thousand |
| Earnings before Tax | -8.62 Million | -8.56 Million | -7.59 Million | -30 Million | -7.16 Million | -7.71 Million |
| Net Income | -8.62 Million | -8.56 Million | -7.59 Million | -30 Million | -7.16 Million | -7.71 Million |
| Earnings Per Share Basic | -0.19 | -0.20 | -0.21 | - | -0.23 | -0.27 |
| Earnings Per Share Diluted | -0.19 | -0.20 | -0.21 | - | -0.23 | -0.27 |
| Weighted Average Shares Outstanding | 45.12 Million | 43.29 Million | 35.8 Million | 29.86 Million | 31.54 Million | 28.47 Million |
| Weighted Average Shares Outstanding (Diluted) | 45.12 Million | 43.29 Million | 35.8 Million | 29.86 Million | 31.54 Million | 28.47 Million |
| Gross Margin | - | - | 0.83 | - | - | - |
| EBIT Margin | - | - | -1.86 | - | - | - |
| Profit Margin | - | - | -2.03 | - | - | - |
| EBITDA | -8.05 Million | -8.56 Million | -6.97 Million | - | -7.16 Million | -7.07 Million |
| Earnings Before Tax Margin | - | - | -2.03 | - | - | - |
ECL
LILAK
HIMX
SAPL
002724
ASQ